You searched for Antibody candidate - Page 33 of 69

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx…

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

Philogen cancer immunotherapy antibody pharma t cell

News and Trends 25 Jan 2019

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to develop new forms of immunotherapy and small molecule drugs. Philogen develops immunocytokines, which are antibodies…

January 25, 2019 - 2 minutesmins - By Jonathan Smith

radiopharmaceutical treatments precirix jeito

News and Trends 17 Mar 2022

€80M Series B Establishes European Champion in Radiopharmaceuticals

…cancer-seeking component is a fragment of an antibody found in animals from the camelid family, which includes llamas and camels. These antibody fragments bind to their targets as strongly as…

March 17, 2022 - 4 minutesmins - By Jonathan Smith

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

…proteins interact with each other, forming aggregates. The team at Axon was able to identify it by developing an antibody that blocked the interaction between tau proteins by targeting that…

September 2, 2020 - 8 minutesmins - By Farhan Mitha

Best in Biotech 9 May 2023

5 cancers that immunotherapy can cure

…for multiple myeloma.The first three approved immunotherapies for multiple myeloma were antibody-based immunotherapies, all approved for subsets of patients with advanced multiple myeloma: daratumumab (Darzalex) – a monoclonal antibody targeting…

May 9, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 20 Jul 2017

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

…a positive opinion for Leo Pharma’s psoriasis drug brodalumab, even though the drug has been associated with suicidal behavior. Brodalumab, a fully human antibody targeting the IL-17 receptor, is part…

July 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 19 Feb 2018

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

Two clinical studies have demonstrated the capacity of Novartis’ monoclonal antibody to treat both plaque and scalp psoriasis and improve patient quality of life. Not only is Novartis leading the…

February 19, 2018 - 3 minutesmins - By Alex Dale

Interview 2 Jan 2017

The Story behind one of the Most Successful Danish Biotech Entrepreneurs

…became co-founders of Symphogen. I was in my 30s and we believed everything was possible, including building the next big antibody company; an idea inspired by Genmab, now a €10Bn…

January 2, 2017 - 6 minutesmins - By Philip Hemme

News and Trends 14 Jun 2017

Understand your Biologics: De-Risking the Biotech Pipeline

…of the top-selling drugs worldwide are antibodies and recombinant proteins, and new technologies such as Antibody-Drug Conjugates (ADCs) are on track to revolutionize the extremely challenging oncology field. However, since…

June 14, 2017 - 5 minutesmins - By External Contributor

Startup Scout 22 Sep 2022

Cartography Biosciences unearths cancer immunotherapy targets

…as partnered programs. Parker said that there are many potential partners out there developing donor cell immunotherapies, engineered antibody drugs and antibody-drug conjugates. “All of them need new targets,” he…

September 22, 2022 - 5 minutesmins - By Jonathan Smith

antibody drug conjugate adc small cancer treatment

News and Trends 5 Oct 2022

Araris Biotech closes $24M financing round for ADCs

…the Araris team as board observers. Proceeds from the financing will be used to support the further development and advancement of Araris’ antibody-drug conjugate (ADC) candidates, created using the company’s…

October 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 11 May 2021

ADC Approval Buoys Spirits in Cancer Treatment Space

The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for blood cancer. This has given a major confidence boost to other European companies in the…

May 11, 2021 - 7 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

€80M Series B Establishes European Champion in Radiopharmaceuticals

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

5 cancers that immunotherapy can cure

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

The Story behind one of the Most Successful Danish Biotech Entrepreneurs

Understand your Biologics: De-Risking the Biotech Pipeline

Cartography Biosciences unearths cancer immunotherapy targets

Araris Biotech closes $24M financing round for ADCs

ADC Approval Buoys Spirits in Cancer Treatment Space

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!